Trial NCT00754923

View at ClinicalTrials.gov 
Org. Study IDs: OSU-08017
Secondary IDs: NCI-2011-03192

Last trial update was posted on 2019-03-06

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Lung Cancer

Stopping Reasons

N/A

Limitations And Caveats

The study was discontinued, after withdrawal from the sponsor due to slow accrual. The discovery of EGFR mutations changed the scope of the trial.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID